Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial

Por Dunbar, Lala M., Milata, Joe, McClure, Ty, Wasilewski, Margaret M.
Publicado em 2011

A phase 1 study of ACE-536, a regulator of erythroid differentiation, in healthy volunteers

Por Attie, Kenneth M, Allison, Mark J, McClure, Ty, Boyd, Ingrid E, Wilson, Dawn M, Pearsall, Amelia E, Sherman, Matthew L
Publicado em 2014

LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study

Por Coakley, Eoin, Ahmad, Alaa, Larson, Kajal, McClure, Ty, Lin, Kai, Lin, Kai, Tenhoor, Kursten, Eze, Kingsley, Noulin, Nicolas, Horvathova, Veronika, Murray, Bryan, Baillet, Mark, Mori, Julie, Adda, Nathalie
Publicado no Open Forum Infect Dis (2019)